Verge Genomics

Verge Genomics is a clinical-stage biotechnology company focused on developing therapeutics for complex diseases with high unmet need. The company uses human genomics from patient disease tissues and machine learning to create its proprietary all-in-human CONVERGE® platform. This platform features one of the field's largest and most comprehensive databases of multi-omic patient data, which Verge uses to identify novel targets and develop drug candidates.

Verge Genomics is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson's disease. They are pioneers in the use of artificial intelligence in drug discovery and development, and they have secured significant investments from leading pharmaceutical companies like Eli Lilly and Alexion AstraZeneca, which underscores the industry's recognition of the company's potential to transform drug discovery.

Verge Genomics is a biotechnology company dedicated to developing better drugs, faster, by leveraging technology. They have created an advanced drug discovery platform powered by artificial intelligence and built upon a large database of multi-omics data sourced directly from human tissue. Their mission is to tackle the biggest medical challenges of our generation, specifically focusing on complex diseases with high unmet need.

Verge Genomics emphasizes a culture of courageous ambition, radical candor, mindfulness, and authenticity. They encourage their employees to embrace risk-taking, acknowledge their emotions, and prioritize open and honest communication. This leads to a workplace where diversity thrives, emotional intelligence is valued, and everyone feels welcome to be their authentic selves.

Verge Genomics actively seeks a diverse applicant pool to build the strongest possible workforce. They prioritize building authentic, high-integrity relationships with each other and encourage vulnerability and emotional intelligence. They embrace courageous ambition, treating every situation as an opportunity to improve with mindfulness, radical candor, and authenticity.